Loss of PIK3CA Allows In Vitro Growth but Not In Vivo Progression of KRAS Mutant Lung Adenocarcinoma in a Syngeneic Orthotopic Implantation Model
Cells · 12.03.2026 · 15 (6) · 506
DOI: 10.3390/cells15060506 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 12.03.2026. Verfasst von Abigail L Booth und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology & Biophysics, Stony Brook University, Stony Brook, NY 11794, USA. Hauptthemen laut MEDLINE: Class I Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins p21(ras), Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, United States Department of Veteran Affairs, LUNGevity Foundation.
Abstract (Originalsprache)
Constitutively active KRAS mutations are highly prevalent in lung cancers, but the direct role of its downstream phosphatidylinositol 3-kinase (PI3K) pathway in tumor progression remains unclear. A previous study established the requirement for PIK3CA, the alpha catalytic isoform, in lung tumor development in mouse models with an intact Trp53 tumor suppressor. In this study, we further investigated the requirement of PIK3CA for tumor growth both in vitro and in vivo. We first generated a “KPA” cell line by genetically deleting Pik3ca from a murine lung adenocarcinoma “KP” cell line harboring oncogenic KrasG12D and lacking Trp53. We also examined the requirement for STK11, a tumor suppressor and metabolic regulator frequently co-mutated with KRAS in lung cancer. We found that Pik3ca is not required for cell survival and growth in vitro, even under anchorage-independent conditions, but reduced the growth rate by 15%. We next orthotopically implanted KP and KPA cells into syngeneic mice and found that PIK3CA is absolutely required for tumor progression, even in the absence of Trp53. Implantation of KP cells, or a “KPS” cell line lacking the Stk11 gene, led to rapid tumor growth and death of all host animals. In contrast, mice implanted with KPA cells all survived with no detectable lung tumors. The gene expression profiles from cultured cell lines suggest oxidative stress as a potential vulnerability of KPA cells. Indeed, we found KPA cells were more sensitive to hydrogen peroxide and diethyl maleate-induced oxidative stress as compared to KP and KPS cells. Together, these results indicate that PIK3CA is not required for lung cancer cell growth induced by mutant KRAS in vitro but is essential for in vivo progression and growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology & Biophysics, Stony Brook University, Stony Brook, NY 11794, USA.
- Molecular and Cellular Biology Graduate Program, Stony Brook University, Stony Brook, NY 11794, USA.
- Stony Brook University Single Cell and Spatial Multiomics Facility, Stony Brook University, Stony Brook, NY 11794, USA.
- Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers-The State University of New Jersey, Piscataway, NJ 08854, USA.
- Northport VA Medical Center, Northport, NY 11768, USA.
ORCID-Profile: Wei-Xing Zong, Harold Bien
Förderung
- BLRD VA
- United States Department of Veteran Affairs
- LUNGevity Foundation
- Stony Brook Medicine
- NCI NIH HHS
- United States (US) Department of Veterans Affairs, Biomedical Laboratory Research and Development Service
- US Department of Veterans Affairs, Clinical Sciences Research and Development Service
- LUNGevity VA Research Scholar Award
Zitieren
APA
Booth, A. L., Caso, G., Rosati, B., Jiang, Y. P., Zong, W. X., Lin, R. Z., & Bien, H. (2026). Loss of PIK3CA Allows In Vitro Growth but Not In Vivo Progression of KRAS Mutant Lung Adenocarcinoma in a Syngeneic Orthotopic Implantation Model. Cells, 15(6), 506. https://doi.org/10.3390/cells15060506
Vancouver
Booth AL, Caso G, Rosati B, Jiang YP, Zong WX, Lin RZ, et al. Loss of PIK3CA Allows In Vitro Growth but Not In Vivo Progression of KRAS Mutant Lung Adenocarcinoma in a Syngeneic Orthotopic Implantation Model. Cells. 2026;15(6):506. doi:10.3390/cells15060506
BibTeX
@article{Booth2026,
author = {Booth, Abigail L and Caso, Giuseppe and Rosati, Barbara and Jiang, Ya-Ping and Zong, Wei-Xing and Lin, Richard Z and Bien, Harold},
title = {Loss of PIK3CA Allows In Vitro Growth but Not In Vivo Progression of KRAS Mutant Lung Adenocarcinoma in a Syngeneic Orthotopic Implantation Model},
journal = {Cells},
year = {2026},
volume = {15},
number = {6},
pages = {506},
doi = {10.3390/cells15060506}
}
EUVIMED